Filing Details
- Accession Number:
- 0001593968-23-000406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-02 21:01:37
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-02 21:01:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1397702 | Silk Road Medical Inc | SILK | Surgical & Medical Instruments & Apparatus (3841) | 208777622 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1770191 | S. Andrew Davis | C/O Silk Road Medical, Inc. 1213 Innsbruck Drive Sunnyvale CA 94089 | Chief Commercial Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-01 | 5,939 | $4.73 | 104,144 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-01 | 5,939 | $48.02 | 98,205 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-03-01 | 814 | $4.73 | 99,019 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-01 | 814 | $48.02 | 98,205 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Disposition | 2023-03-01 | 5,939 | $0.00 | 5,939 | $4.73 |
Common Stock | Option (right to buy) | Disposition | 2023-03-01 | 814 | $0.00 | 814 | $4.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
48,926 | 2017-09-01 | 2027-11-30 | No | 4 | M | Direct |
26,270 | 2021-04-04 | 2027-11-30 | No | 4 | M | Direct |
Footnotes
- The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
- This transaction was executed in multiple trades at price ranging from $47.37 to $48.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- All of the shares subject to this option are fully vested and exercisable as of the date hereof.